Richard W. Paul & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15K | Sell |
135
-79
| -37% | -$8.76K | 0.01% | 232 |
|
|
2025
Q1 | $24K | Sell |
214
-65
| -23% | -$7.28K | 0.01% | 209 |
|
|
2024
Q4 | $25.8K | Sell |
279
-31
| -10% | -$2.86K | 0.01% | 234 |
|
|
2024
Q3 | $26K | Buy |
310
+29
| +10% | +$2.43K | 0.01% | 238 |
|
|
2024
Q2 | $19.3K | Buy |
281
+46
| +20% | +$3.16K | 0.01% | 255 |
|
|
2024
Q1 | $17.2K | Buy |
235
+102
| +77% | +$7.47K | 0.01% | 273 |
|
|
2023
Q4 | $10.8K | Sell |
133
-21
| -14% | -$1.7K | ﹤0.01% | 297 |
|
|
2023
Q3 | $11.5K | Sell |
154
-9
| -6% | -$674 | 0.01% | 281 |
|
|
2023
Q2 | $12.6K | Sell |
163
-95
| -37% | -$7.32K | 0.01% | 300 |
|
|
2023
Q1 | $21.4K | Sell |
258
-368
| -59% | -$30.5K | 0.01% | 261 |
|
|
2022
Q4 | $53.7K | Buy |
+626
| New | +$53.7K | 0.03% | 215 |
|